Why the Sonic Healthcare (ASX:SHL) share price hit an all-time high today

The pathology provider's share price is up amid growing demand for COVID-19 testing.

| More on:

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 6 March 2025

elderly woman cheers in doctor's office

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price hit a new record high today, extending its run in the green.

Sonic Healthcare shares are now exchanging hands for $39.65 apiece, just shy of the day high and all-time high $39.86. This represents a 1.43% rise on its previous closing price.

Let's take a look at what's driving the Sonic share price today.

But first – what is Sonic Healthcare?

Sonic is a global pathology provider with large market share in Australia, Europe and the United States.

The Sydney-based company also has a large footprint in diagnostic imaging in the Australian market.

Sonic Healthcare has been a solid performer on the ASX, seeing a share price increase of ~80% since January 2019.

What is behind today's share price movement?

Investment banking giant Goldman Sachs thinks the COVID-19 testing market will continue to run hot in the near term.

Surging case numbers, fuelled by the new Delta variant of the virus, is driving COVID-19 test volumes, according to Goldman.

It believes Sonic is well positioned to benefit from these tailwinds, given "PCR testing volumes have increased significantly" in recent weeks.

In its report, Goldman Sachs said:

Given the materiality of COVID-19 testing for the ASX-listed pathology providers, [Sonic], HLS and ACL (GSe: 17-28% of FY21E revenues), our new PCR volume estimates drive +6-10% EBIT upgrades in FY21E and +9-47% in FY22E.

Investors seem to like the analysis on Sonic Healthcare shares, as trading volume surged higher than the 20-day average this morning, helping prop the share price northwards.

Sonic Healthcare share price snapshot

Sonic Healthcare shares have posted a year-to-date return of 23%. This extends the previous 12-month return to 26%.

The pathology provider is going from strength to strength, and has set five all-time highs since 30 June. The company has outpaced the S&P/ASX 200 Index (ASX: XJO)'s return of ~11% since 1 January.

Based on the current share price, Sonic Healthcare has a market capitalisation of around $19 billion.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A businessman hugs his computer and smiles.
Share Market News

3 ASX ETFs I would buy and hold for a decade

These funds could compound your wealth over the next 10 years.

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

10 ASX shares to buy after the market selloff

Analysts think these shares could be strong buys after recent weakness. Let's see what they are recommending.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was carnage on the ASX today.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

ASX 200 plunges as US tariffs fall-out continues

The ASX 200 benchmark index fell by almost 200 points on Friday.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Opinions

ASX shares are on sale! What are you buying?

Stocks are being hit hard. There are opportunities everywhere.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in April

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

woman holding 'hiring' sign in shop
Share Market News

Why is tonight's US jobs report so significant for global markets?

With Liberation Day in the rearview mirror, global equity markets will be looking towards tonight's US jobs data.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX 200 shares rocketing higher in this month's falling market

A handful of ASX 200 shares managed to fly higher this past month. But how?

Read more »